Michael Ahdoot
Overview
Explore the profile of Michael Ahdoot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahdoot M, Naser-Tavakolian A, Heard J, Williams C, Daneshvar M, Gomella P, et al.
J Urol
. 2025 Feb;
:101097JU0000000000004480.
PMID: 39951686
Purpose: The addition of systematic prostate biopsy enhances the detection of clinically significant prostate cancer compared with MRI-targeted biopsy alone. However, there is growing interest in using only MRI-targeted biopsy....
2.
Heard J, Ahdoot M, Theodorescu D, Mitra A
Expert Rev Mol Diagn
. 2024 Nov;
24(10):957-969.
PMID: 39535158
Introduction: There have been many recent advancements in the treatment of bladder cancer including the approval of novel intravesical agents for non-muscle-invasive disease and systemic-targeted therapeutics for muscle-invasive and advanced...
3.
Kheshvadjian M, Nazmifar M, Rawal R, Davood J, Castaneda P, Dadashian E, et al.
Urology
. 2024 Jun;
191:185-192.
PMID: 38936623
Objective: To improve our previous simulation-based training module by using sustainable material to mold an anatomically accurate terrain and reproducing major vascular injuries encountered during robot-assisted nephrectomy. Methods: The simulator...
4.
Gomella P, Solomon J, Ahdoot M, Gurram S, Lebastchi A, Levy E, et al.
Urol Oncol
. 2024 Apr;
42(7):222.e1-222.e7.
PMID: 38614921
Introduction: Delayed bleeding is a potentially serious complication after partial nephrectomy (PN), with reported rates of 1%-2%. Patients with multiple renal tumors, including those with hereditary forms of kidney cancer,...
5.
Guo C, Zhao M, Sui X, Balsara Z, Zhai S, Ahdoot M, et al.
iScience
. 2023 Jun;
26(6):106925.
PMID: 37332606
Urinary tract infection (UTI) is a pervasive health problem worldwide. Patients with a history of UTIs suffer increased risk of recurrent infections, a major risk of antibiotic resistance. Here, we...
6.
Castaneda P, Theodorescu D, Rosser C, Ahdoot M
Front Oncol
. 2023 Apr;
13:1114203.
PMID: 37064102
Bladder cancer is a complex disease with variable prognosis. Recent investigations into the molecular landscape of bladder cancer have revealed frequent genetic alterations and molecular subtypes with therapeutic implications. Consequently,...
7.
Kenigsberg A, Ahdoot M, Turkbey B, Pinto P
Eur Urol
. 2023 Mar;
83(6):582-583.
PMID: 36907691
No abstract available.
8.
Castaneda P, Ahdoot M, Rosser C
J Urol
. 2023 Feb;
209(4):678-679.
PMID: 36753683
No abstract available.
9.
Naser-Tavakolian A, Nazmifar M, Ahdoot M
J Urol
. 2022 Sep;
208(6):1211-1212.
PMID: 36097866
No abstract available.
10.
Nazmifar M, Williams C, Naser-Tavakolian A, Heard J, Rosser C, Theodorescu D, et al.
J Urol
. 2022 Sep;
209(1):32-48.
PMID: 36067380
Purpose: Intravesical bacillus Calmette-Guérin is the current first-line treatment for high-grade nonmuscle-invasive bladder cancer; however, a substantial proportion of patients are unresponsive to bacillus Calmette-Guérin treatment. While cystectomy is often...